A blue background with circles and lines in the center.
A view of the town from above.

About Us: Redefining Wound Healing with BioHeal Hydrogel XG-100

At BIOHEAL THERAPEUTICS, we are redefining how chronic wounds, burns, and post-surgical wounds are treated. Our flagship product, BioHeal Hydrogel XG-100, is a tear-resistant, hydrogel wound covering designed to address the limitations of traditional amnion sheets. Developed for ease of use, superior conformability, and workflow efficiency, BioHeal Hydrogel brings next-generation healing science to clinical practice.

Note: BioHeal Hydrogel XG-100 is currently under development and not yet available in the United States.

Pioneering the Future of Regenerative Wound Care

Through an exclusive global license with the Wake Forest Institute for Regenerative Medicine (WFIRM), we are advancing amnion-derived technologies with real-world clinical utility. Our mission is to develop wound care solutions that:

  • Support wound closure and tissue regeneration

  • Enhance healing of chronic wounds, second-degree burns, and surgical wounds

  • Simplify the delivery of topical therapies for frontline providers

Expanding What’s Possible in Wound Care

Our innovation pipeline is focused on:

  • Improving clinical outcomes while simplifying application

  • Introducing easy-to-use formats that reduce cost and complexity

  • Developing scalable, shelf-stable solutions across wound care and dermatology

We are committed to delivering science-backed, clinician-friendly products that meet the evolving demands of today’s healthcare system.

Built by Experts in Regenerative Medicine

BIOHEAL THERAPEUTICS was founded by Bruce Anderson and Steve Anderson, bringing together over 70 years of leadership in medical device development and biologics. Our team has played key roles in the successful commercialization of implantable cardiovascular, orthopedic, and wound care technologies.

A Legacy of Innovation, Based in Greater Atlanta

Headquartered in Greater Atlanta, Georgia, BIOHEAL THERAPEUTICS is driven by a single purpose: to advance regenerative medicine with practical, high-impact solutions that elevate patient care and provider efficiency.

We are creating the next chapter in wound healing—with products that are simple to use, cost effective, and built for today’s clinical environment.

 

Meet the Team

Bruce Anderson

President & CEO

Bruce Anderson is a category-defining innovator in regenerative medicine and surgical hydrogel technologies, with over 25 years of experience turning breakthrough science into commercial success. As cofounder and CEO of BIOHEAL THERAPEUTICS, founded in 2017, Anderson is leading the development of BioHeal Hydrogel XG-100, a novel, biologically active hydrogel designed for chronic wounds, burns, and topical post surgical procedures. By combining solubilized porcine amnion and hyaluronic acid, BIOHEAL is establishing advanced topical regenerative therapies.

Anderson's journey as a hydrogel pioneer began with BioGlue, the world's first FDA-approved protein-based surgical adhesive, cleared in 1999 under Humanitarian Device Exemption for use in the repair of acute thoracic aortic dissection. He played a key role in its clinical positioning and commercial success, helping to create a new standard in cardiovascular surgery and opening the door to a global market for surgical sealants.

Throughout his career, Anderson has contributed to the development and commercialization of more than 20 implantable human cardiovascular and orthopedic tissues and multiple Class II and III medical devices-consistently redefining what's possible in tissue-based and regenerative technologies.

In 2008, he was elected Vice President of US Sales and Global Marketing for Artivion (formerly CryoLife, Inc.), where he led a team of over 120 professionals across global product marketing. From 2002 to 2007, he served as Director of US Sales, driving double-digit growth in the company's portfolio during a critical phase of expansion.

Mr. Anderson holds a degree from the University of South Florida at Tampa.

Steve Anderson (1939-2023): A Legacy of Innovation in Medical Devices

Steve Anderson was the Chairman of the Board and co-founder of BIOHEAL THERAPEUTICS, LLC, serving from its founding 2017 until his passing in 2023. A visionary entrepreneur and industry pioneer, he dedicated his career to advancing life-saving medical technologies.

Mr. Anderson was also the co-founder, President, CEO of CryoLife, Inc. (now Artivion) from 1984 - 2015. Under his leadership, the company went public on Nasdaq in 1994 and transitioned to the New York Stock Exchange in 1997.

Before founding CryoLife, he held key executive roles in the medical device industry:

A Legacy of Impact

CryoLife's cardiac tissues revolutionized pediatric reconstructive surgery, helping to save the lives of thousands of children, while its vascular tissues preserved the limbs of thousands of adults suffering from peripheral vascular disease. CryoLife’s products have reached 80 countries, and its cryopreserved human tissues and surgical adhesives have improved the lives of nearly 2 million people worldwide.

A true entrepreneur, pioneer, and leader in the medical device industry, Mr. Anderson’s contributions transformed cardiovascular surgery and tissue transplantation.

He was a graduate of the University of Minnesota at Minneapolis.